Investor · New York, NY

Carl L. Gordon

Open Carl in the network graph →

Filings

243

SEC Form D

Connections

996

co-filers

Capital

$2.2B

across filings

Active

Feb 2014

to Dec 2025

Most-connected co-filers (996)

Geoffrey C. Hsu · New York, NY72 shared W. C. Neild · New York, NY72 shared Sven H. Borho · New York, NY71 shared Jonathan T. Silverstein · New York, NY44 shared OrbiMed Advisors LLC · New York, NY40 shared C. S. Stevens · New York, NY35 shared David P. Bonita · New York, NY32 shared George R. Roberts · New York, NY24 shared Samuel D. Isaly · New York, NY24 shared Peter A. Thompson · New York, NY21 shared Matthew S. Rizzo · New York, NY21 shared OrbiMed Global Healthcare GP LLC · New York, NY17 shared Erez Chimovits · Herzeliya, L316 shared Orbimed Advisors Llc · New York, NY15 shared Orbimed Advisors Llc · New York, NY15 shared John Diekman · Menlo Park, CA13 shared Peter B. Hutt · CAMBRIDGE, MA13 shared Robert J. More · Alpharetta, GA12 shared Eric Bertrand · Ta'Xbiex, O112 shared Richard J. Wells · New York, NY12 shared David J. Sorkin · New York, NY11 shared Robert Schreiber · Burlingame, CA11 shared Mark L. Lane · Greenwood Village, CO10 shared Lloyd M. Johnston · Watertown, MA10 shared

Recent filings (243)

BlossomHill Therapeutics, Inc.Dec 2025 · 14 co-filers$84.2M BlossomHill Therapeutics, Inc.Dec 2025 · 14 co-filers$84.2M BlossomHill Therapeutics, Inc.Dec 2025 · 14 co-filers$84.2M OrbiMed Genesis Fund, L.P.Dec 2025 · 13 co-filers Star Therapeutics LLCOct 2025 · 24 co-filers$125.0M Star Therapeutics LLCOct 2025 · 24 co-filers$125.0M Star Therapeutics LLCOct 2025 · 24 co-filers$125.0M OrbiMed Private Investments X, LPSep 2025 · 15 co-filers$1.8B OrbiMed Asia Partners VI, L.P.Sep 2025 · 11 co-filers$850.0M Avenzo Therapeutics, Inc.Sep 2025 · 11 co-filers$75.0M OrbiMed Partners II, L.P.Jul 2025 · 24 co-filers OrbiMed Royalty & Credit Opportunities V, LPMay 2025 · 14 co-filers$1.8B OrbiMed RCO V Offshore Feeder, LPMay 2025 · 14 co-filers$1.8B Lomond Therapeutics Holdings, Inc.Feb 2025 · 8 co-filers$63.9M Lomond Therapeutics Holdings, Inc.Feb 2025 · 8 co-filers$63.9M Lomond Therapeutics Holdings, Inc.Feb 2025 · 8 co-filers$63.9M OrbiMed Genesis Fund, L.P.Dec 2024 · 12 co-filers Avenzo Therapeutics, Inc.Nov 2024 · 10 co-filers$385.9M Lomond Therapeutics Holdings, Inc.Nov 2024 · 4 co-filers$43.9M OrbiMed Royalty & Credit Opportunities V, LPNov 2024 · 15 co-filers$1.8B OrbiMed RCO V Offshore Feeder, LPNov 2024 · 15 co-filers$1.8B Garuda Therapeutics, Inc.Oct 2024 · 8 co-filers Belenos Biosciences, Inc.Jul 2024 · 10 co-filers$55.0M OrbiMed Partners II, L.P.Jul 2024 · 24 co-filers BRC Emerging Managers Fund of Funds, LPJun 2024 · 17 co-filers

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Carl in the interactive graph →